Inc. (Nasdaq: TSVT) today provided full-year Abecma® (idecabtagene vicleucel; ide-cel) sales results for 2024, in partnership with Brist ...

NGAD represents just one component of a broader effort to keep pace with adversaries such as Russia and China. In recent ...

A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new research.

One of the most powerful aspects of reading is that it’s an adventure you don’t have to leave home to experience. Whether ...

In the latest episode of "The Envelope" video podcast, director Coralie Fargeat explains how she prepared star Demi Moore to film "The Substance" and "The Brutalist" filmmaker Brady Corbet discusses ...

A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new research led by investigators at the Johns Hopkins Kimmel ...

Driven by consumer demand for more sustainable packaging, CPGs turn to new materials such as paper and bio-based/compostable ...

Q4 2024 Results Conference Call February 11, 2025 4:00 AM ETCompany ParticipantsIngela Ulfves - Head of Investor ...

A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, ...

South Korea's bioimpedance sensor market thrives on government funding, technological innovation, wearable integration, and healthcare adoption, driv ...